Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Deaths and disability from natalizumab are no longer tolerable : No - (they can be avoided). / Sørensen, Per Soelberg.
In: Multiple Sclerosis, Vol. 18, No. 8, 2012, p. 1070-2.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Sørensen, PS 2012, 'Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)', Multiple Sclerosis, vol. 18, no. 8, pp. 1070-2. https://doi.org/10.1177/1352458512451946
APA
Sørensen, P. S. (2012). Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided). Multiple Sclerosis, 18(8), 1070-2. https://doi.org/10.1177/1352458512451946
Vancouver
Sørensen PS. Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided). Multiple Sclerosis. 2012;18(8):1070-2. https://doi.org/10.1177/1352458512451946
Author
Bibtex
@article{ebc5e9fa95504046b0cbba2cf395dc8c,
title = "Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)",
author = "S{\o}rensen, {Per Soelberg}",
year = "2012",
doi = "10.1177/1352458512451946",
language = "English",
volume = "18",
pages = "1070--2",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "8",
}
RIS
TY - JOUR
T1 - Deaths and disability from natalizumab are no longer tolerable
T2 - No - (they can be avoided)
AU - Sørensen, Per Soelberg
PY - 2012
Y1 - 2012
U2 - 10.1177/1352458512451946
DO - 10.1177/1352458512451946
M3 - Journal article
C2 - 22807471
VL - 18
SP - 1070
EP - 1072
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
SN - 1352-4585
IS - 8
ER -
ID: 48584462